Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1Университет им. Давида Бен-Гуриона в Негеве. 8410501, Израиль, Беер-Шева; 2ФГБОУ ВО Ставропольский государственный медицинский университет Минздрава России, 355017, Россия, Ставрополь, ул. Мира, д. 310
R.A.Bekker1, Yu.V.Bykov2 1David Ben-Gurion University in the Negev. 8410501, Israel, BeerSheva; 2Stavropol State Medical University of the Ministry of Health of the Russian Federation. 355017, Russian Federation, Stavropol, ul. Mira, d. 310
Список исп. литературыСкрыть список 1. Акарачкова Е.С. К вопросу диагностики и лечения психовегетативных расстройств в общесоматической практике. Лечащий врач. 2010; 10: 5–8. / Akarachkova E.S. K voprosu diagnostiki i lecheniia psikhovegetativnykh rasstroistv v obshchesomaticheskoi praktike. Lechashchii vrach. 2010; 10: 5–8. [in Russian] 2. Алешина Н.В. Применение препарата «Тералиджен» в структуре фармакотерапии раннего детского аутизма (процессуального и органического). Психическое здоровье. 2014; 2 (93): 70–2. / Aleshina N.V. Primenenie preparata «Teralidzhen» v strukture farmakoterapii rannego detskogo autizma (protsessual'nogo i organicheskogo). Psikhicheskoe zdorov'e. 2014; 2 (93): 70–2. [in Russian] 3. Алешина Н.В., Филиппова Н.В., Барыльник Ю.Б. Тералиджен в комплексной терапии органического и процессуального раннего детского аутизма. Междунар. научно-исследовательский журн. 2014; 2–3 (21): 89–90. / Aleshina N.V., Filippova N.V., Baryl'nik Iu.B. Teralidzhen v kompleksnoi terapii organicheskogo i protsessual'nogo rannego detskogo autizma. Mezhdunar. nauchno-issledovatel'skii zhurn. 2014; 2–3 (21): 89–90. [in Russian] 4. Асташенко А.П. Тревога и депрессия у детей с соматическими заболеваниями. Бюл. мед. интернет-конференций. 2014; 5 (4): 645. / Astashenko A.P. Trevoga i depressiia u detei s somaticheskimi zabolevaniiami. Biul. med. internet-konferentsii. 2014; 5 (4): 645. [in Russian] 5. Баранцевич Е.Р., Головкова М.С., Джулай И.А. и др. Эффективность и безопасность применения препарата Тералиджен у пациентов с дисциркуляторной энцефалопатией I и II стадий и психовегетативным синдромом. Журн. неврологии и психиатрии им. C.C.Корсакова. 2015; 12 (115): 86–91. / Barantsevich E.R., Golovkova M.S., Dzhulai I.A. i dr. Effektivnost' i bezopasnost' primeneniia preparata Teralidzhen u patsientov s distsirkuliatornoi entsefalopatiei I i II stadii i psikhovegetativnym sindromom. Zhurn. nevrologii i psikhiatrii im. C.C.Korsakova. 2015; 12 (115): 86–91. [in Russian] 6. Воробьева О.В., Русая В.В. Вегетативная дисфункция, ассоциированная с тревожными расстройствами. Эффективная фармакотерапия. 2011; 17: 46–50. / Vorob'eva O.V., Rusaia V.V. Vegetativnaia disfunktsiia, assotsiirovannaia s trevozhnymi rasstroistvami. Effektivnaia farmakoterapiia. 2011; 17: 46–50. [in Russian] 7. Вотчал Б.Е. Очерки клинической фармакологии. Изд. 2-е. М.: 1965. / Votchal B.E. Ocherki klinicheskoi farmakologii. Izd. 2-e. M.: 1965. [in Russian] 8. Данилов Д.С. Индивидуальный выбор современной психофармакотерапии шизофрении (основные принципы, обсуждение результатов клинических исследований и некоторые практические рекомендации). Психиатрия и психофармакотерапия (Журнал им. П.Б.Ганнушкина). 2008; 6 (10): 50–7. / Danilov D.S. Individual'nyi vybor sovremennoi psikhofarmakoterapii shizofrenii (osnovnye printsipy, obsuzhdenie rezul'tatov klinicheskikh issledovanii i nekotorye prakticheskie rekomendatsii). Psikhiatriia i psikhofarmakoterapiia (Zhurnal im. P.B.Gannushkina). 2008; 6 (10): 50–7. [in Russian] 9. Зуева Г.А. Опыт применения алимемазина тартрата для коррекции нарушений сна у подростков с головной болью напряжения. В кн.: Актуальные вопросы реабилитации в неврологии и психиатрии. Материалы научно-практической конференции. ГБОУ ВПО Тверская ГМА Минздрава России. Тверь, 2014: 16–8. / Zueva G.A. Opyt primeneniia alimemazina tartrata dlia korrektsii narushenii sna u podrostkov s golovnoi bol'iu napriazheniia. V kn.: Aktual'nye voprosy reabilitatsii v nevrologii i psikhiatrii. Materialy nauchno-prakticheskoi konferentsii. GBOU VPO Tverskaia GMA Minzdrava Rossii. Tver', 2014: 16–8. [in Russian] 10. Любимов А.В., Карчаа А.Р. Применение препарата Тералиджен в терапии надсегментарных (церебральных) вегетативных нарушений. Научные ведомости Белгородского государственного университета. Серия: Медицина. Фармация. 2012; 4 (17): 20–5. / Liubimov A.V., Karchaa A.R. Primenenie preparata Teralidzhen v terapii nadsegmentarnykh (tserebral'nykh) vegetativnykh narushenii. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. Seriia: Meditsina. Farmatsiia. 2012; 4 (17): 20–5. [in Russian] 11. Малинина Е.В., Чижова Т.Н., Забозлаева И.В., Пирогова А.В. Исследование эффективности и переносимости алимемазина у детей со смешанными расстройствами эмоций и поведения. Доктор.Ру. 2015; 5–6: 67–70. / Malinina E.V., Chizhova T.N., Zabozlaeva I.V., Pirogova A.V. Issledovanie effektivnosti i perenosimosti alimemazina u detei so smeshannymi rasstroistvami emotsii i povedeniia. Doktor.Ru. 2015; 5–6: 67–70. [in Russian] 12. Поздеев О.П. Состояние тревоги и депрессии при атопическом дерматите. Здоровье, демография, экология финно-угорских народов. 2011; 2: 38–9. / Pozdeev O.P. Sostoianie trevogi i depressii pri atopicheskom dermatite. Zdorov'e, demografiia, ekologiia finno-ugorskikh narodov. 2011; 2: 38–9. [in Russian] 13. Полуэктов М.Г. Нарушения сна в детском возрасте: причины и современная терапия. Эффективная фармакотерапия. 2012; 1: 32–9. / Poluektov M.G. Narusheniia sna v detskom vozraste: prichiny i sovremennaia terapiia. Effektivnaia farmakoterapiia. 2012; 1: 32–9. [in Russian] 14. Попов Д.В., Ширяев О.Ю., Будневский А.В. Анализ динамики тревожно-депрессивных расстройств у больных бронхиальной астмой на фоне терапии Тералидженом. Прикладные информационные аспекты медицины. 2012; (15): 53–6. / Popov D.V., Shiriaev O.Iu., Budnevskii A.V. Analiz dinamiki trevozhno-depressivnykh rasstroistv u bol'nykh bronkhial'noi astmoi na fone terapii Teralidzhenom. Prikladnye informatsionnye aspekty meditsiny. 2012; (15): 53–6. [in Russian] 15. Прибытков А.А., Орлова Е.А. Психосоматические расстройства с проявлениями в виде уртикарной сыпи. Психические расстройства в общей медицине. 2014; 2: 47–53. / Pribytkov A.A., Orlova E.A. Psikhosomaticheskie rasstroistva s proiavleniiami v vide urtikarnoi sypi. Psikhicheskie rasstroistva v obshchei meditsine. 2014; 2: 47–53. [in Russian] 16. Пушкарев Д.Ф. Алимемазин в психиатрической практике и общей медицине (обзор литературы). Психические расстройства в общей медицине. 2013; 1: 56–61. / Pushkarev D.F. Alimemazin v psikhiatricheskoi praktike i obshchei meditsine (obzor literatury). Psikhicheskie rasstroistva v obshchei meditsine. 2013; 1: 56–61. [in Russian] 17. Рагинене И.Г., Ахапкин Ф.А. Сомнологические и вегетативные нарушения у больных неврологического профиля с острой сосудистой патологией. Эффективная фармакотерапия. 2014; 49: 4–7. / Raginene I.G., Akhapkin F.A. Somnologicheskie i vegetativnye narusheniia u bol'nykh nevrologicheskogo profilia s ostroi sosudistoi patologiei. Effektivnaia farmakoterapiia. 2014; 49: 4–7. [in Russian] 18. Барденштейн Л.М., Молодецких А.В., Можгинский Ю.Б. и др. Алкоголизм, наркомании и другие психические и поведенческие расстройства, связанные с употреблением психоактивных веществ. Учеб. пособ. М.: ГЭОТАР-Медиа, 2015. / Bardenshtein L.M., Molodetskikh A.V., Mozhginskii Iu.B. i dr. Alkogolizm, narkomanii i drugie psikhicheskie i povedencheskie rasstroistva, sviazannye s upotrebleniem psikhoaktivnykh veshchestv. Ucheb. posob. M.: GEOTAR-Media, 2015. [in Russian] 19. Скворцов В.В., Тумаренко А.В., Орлов О.В. Нейроциркуляторная дистония: актуальные вопросы диагностики и лечения. Лечащий врач. 2008; 5: 12–7. / Skvortsov V.V., Tumarenko A.V., Orlov O.V. Neirotsirkuliatornaia distoniia: aktual'nye voprosy diagnostiki i lecheniia. Lechashchii vrach. 2008; 5: 12–7. [in Russian] 20. Этингоф А.М. Эффективность и безопасность Тералиджена в повседневной практике. Фарматека. 2014; 19 (292): 8–13. / Etingof A.M. Effektivnost' i bezopasnost' Teralidzhena v povsednevnoi praktike. Farmateka. 2014; 19 (292): 8–13. [in Russian] 21. Alicino R. The premenstrual syndrome. Treatment with Farlutens (results and advantages). (Article in Italian). Clin Ostet Ginecol 1963; 65: 182–90. 22. Antao B, Ooi K, Ade-Ajayi N et al. Effectiveness of alimemazine in controlling retching after Nissen fundoplication. J Pediatr Surg 2005; 40 (11): 1737–40. 23. Ayd FJJr, Bianco EA, Zullo LM. Trimeprazine therapy for physiologic and psychologic pruritus. South Med J 1959; 52: 1554–6. 24. Baruk H, Launay J. Imipramine and alimemazine. Application of the law of stages. (Article in French). Ann Med Psychol (Paris) 1960; 118 (2): 923–5. 25. Bello LL. Factors affecting efficacy of oral trimeprazine sedation for dental procedures in children: A retrospective study. Saudi Dent J 2011; 23 (2): 87–90. 26. Berkovitz D. The effect of a long–acting preparation (spansule) of belladonna alkaloids on gastric secretion of patients with peptic ulcer. Gastroenterology 1956; 30 (4): 608–12. 27. Brzezicki E, Ryn Z. Treatment of elderly mental patients with trimeprazine. (Problems of psychopharmacology). Mater Med Pol 1971; 3 (2): 32–4. 28. Burger W. Lytic therapy of asthma with the new phenothiazine derivative repeltin. (Article in German). Med Nov 1959; 47: 2290–3. 29. Callaway JL, Olansky S. Trimeprazine: an adjuvant in the management of itching dermatoses. N C Med J 1957; 18 (8): 320–1. 30. Cirilli M. Treatment of delirium tremens with alimemazine. (Article in French). Gaz Hop Civ Mil Empire Ottoman 1961; 68: 951–2. 31. De Groote J, Gomand L, Van de Mierop L. Clinical studies with oxomemazine in gastroenterology: more specifically in esophago–gastric pathology. (Article in Dutch). Tijdschr Gastroenterol 1966; 9 (4): 371–8. 32. Dupuis LL, Nathan PC. Options for the prevention and management of acute chemotherapy-induced nausea and vomiting in children. Paediatr Drugs 2003; 5 (9): 597–613. 33. Fernandez Zoila A, Basset J, Lebreton M. Trial therapy of depressive states using alimemazine a tartrate. (Article in French). Ann Med Psychol (Paris) 1959; 117 (3): 557–64. 34. Fischer RW. Comparison of antipruritic agents administered orally. A double-blind study. JAMA 1968; 203 (6): 418–19. 35. Genois A, Haig M, Des Roches A et al. Case report of atopic dermatitis with refractory pruritus markedly improved with the novel use of clonidine and trimeprazine. Pediatr Dermatol 2014; 31 (1): 76–9. 36. Glusa E, Pertz HH. Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT(2B) receptors. Br J Pharmacol 2000; 130 (3): 692–8. 37. Goh JC, Ng AS, Sim KM. Postoperative vomiting (POV) in the paediatric outpatient general surgical population. Singapore Med J 1999; 40 (3): 144–6. 38. Gordon NH, Turner DJ. Oral paediatric premedication. A comparative trial of either phenobarbitone, trimeprazine or diazepam with hyoscine, prior to guillotine tonsillectomy. Br J Anaesth 1969; 41(2): 136–42. 39. Hedlund PB. The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology (Berl). 2009; 206 (3): 345–54. 40. Heyman SN, Mevorach D, Ghanem J. Hypertensive crisis from chronic intoxication with nasal decongestant and cough medications. DICP 1991; 25 (10): 1068–70. 41. Ibragimov DF. Alimemazine in medical practice. (Article in Russian). Zh Nevrol Psikhiatr Im SS Korsakova 2008; 108 (9): 76–8. 42. Jones RS. The management of acute croup. Arch Dis Child 1972; 47 (254): 661–8. 43. Kale RK, Sitasawad SL. Modification of radiation induced lipid peroxidation by calmodulin antagonists. Indian J Exp Biol 1990; 28 (8): 757–61. 44. Kelley NE, Tepper DE. Rescue therapy for acute migraine, part 2: neuroleptics, antihistamines, and others. Headache 2012; 52 (2): 292–306. 45. Kohen R, Metcalf MA, Khan N et al. Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor. J Neurochem 1996; 66 (1): 47–56. 46. Krause L, Shuster S. Mechanism of action of antipruritic drugs. Br Med J (Clin Res Ed) 1983; 287 (6400): 1199–200. 47. Kroeze WK, Hufeisen SJ, Popadak BA et al. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 2003; 28 (3): 519–26. 48. Layfield DJ, Walker AK. Premedication for children with oral trimeprazine and droperidol. Anaesthesia 1984; 39 (1): 32–4. 49. Lingjaerde O. Alimemazine (Vallergan) as hypnotic in general practice. Pilot project and double–blind comparison with placebo. (Article in Norwegian). Tidsskr Nor Laegeforen 1978; 98 (16): 828–31. 50. London I D. Double-blind evaluation of trimeprazine, an oral antipruritic. AMA Arch Derm 1959; 80 (2): 220–1. 51. London ID. Trimeprazine, an oral antipruritic; a clinical and double-blind evaluation. J Med Assoc State Ala 1959; 28 (11): 342–5. 52. McClellan M. Antitussive effects of trimeprazine (temaril) in children. Ohio Med 1960; 56: 1358–9. 53. Mendham JE. Gabapentin for the treatment of itching produced by burns and wound healing in children: a pilot study. Burns 2004; 30 (8): 851–3. 54. Menzel M. Experience with theralene (alimemazine) in internal medicine. (Article in German). Med Klin 1964; 59: 1438–40. 55. Miller J. Antipruritic potency of a new antihistamine dimethpyrindene: a comparative study with trimeprazine, a phenothiazine antihistamine. Curr Ther Res Clin Exp 1962; 4: 115–23. 56. Milstein J. Clinical trials of RP 6549 (theralene) in functional digestive disorders. (Article in French). Sem Med Prof Med Soc 1959; 35: 102–5. 57. Mindell JA, Kuhn B, Lewin DS et al. Behavioral treatment of bedtime problems and night wakings in infants and young children. Sleep 2006; 29 (10): 1263–76. 58. Mohammadi R, Gaudoneix-Taieb M, Armand-Branger S et al. Value of trimeprazine among hypnotics in a psychiatric facility. (Article in French). Encephale 2000; 26 (5): 75–80. 59. Oftsti E. Alimemazine (Vallergan) an alternative to traditional hypnotic drugs. (Article in Norwegian). Tidsskr Nor. 60. Persyn JT, McDonough JA, Nino JA et al. Mucosal delivery of cytotoxic therapeutic agents: response of rat nasal mucosa to microencapsulated ethopropazine HCl enantiomer. J Microencapsul 2005; 22 (7): 737–44. 61. Peterkin GA. Otitis externa. J Laryngol Otol 1974; 88 (1): 15–21. 62. Peters CG, Brunton JT. Comparative study of lorazepam and trimeprazine for oral premedication in paediatric anaesthesia. Br J Anaesth 1982; 54 (6): 623–8. 63. Petersen EN. Pre- and postsynaptic alpha-adrenoceptor antagonism by neuroleptics in vivo. Eur J Pharmacol 1981; 69 (4): 399–405. 64. Pujet JC, Keddad K, Sévenier F et al. Comparative study of two antitussive drugs in the treatment of acute dry cough of infectious origin (prospective, randomized, single blind study). (Article in French). Therapie 2002; 57 (5): 457–63. 65. Puttick N, Van der Walt JH. The effect of premedication on the incidence of postoperative vomiting in children after E.N.T. surgery. Anaesth Intensive Care 1987; 15 (2): 158–62. 66. Radó JP, Simon T, Juhos E et al. Interference of psychotropic drugs with cortisol determinations. Horm Metab Res 1974; 6 (6): 530–1. 67. Rafstedt S. Medical treatment of habitual vomiting. Acta Paediatr (Suppl.) 1963; 146: 122–4. 68. Roche L, Vedrinne J, Motin J. Significance of Alimemazine in the treatment of delirium tremens. (Article in French). Lyon Med 1963; 95: 255–71. 69. Roth BL, Craigo SC, Choudhary MS et al. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 1994; 268 (3): 1403–10. 70. Sadeg N, Richecoeur J, Dumontet M. Intoxication from venlafaxine combined with benzodiazepines, lithium and alimemazine. (Article in French). Therapie 2000; 55 (2): 322–5. 71. Saginario M, Passeri S Treatment of the premenstrual syndrome in some neuropsychiatric conditions. (Article in Italian). G Psichiatr Neuropatol 1965; 93 (3): 884–7. 72. Sanders CD. Trimeprazine tartrate (vallergan) as a premedicative drug in children. J R Army Med Corps 1960; 106: 26–7. 73. Savin JA, Paterson WD, Adam K et al. Effects of trimeprazine and trimipramine on nocturnal scratching in patients with atopic eczema. Arch Dermatol 1979; 115 (3): 313–5. 74. Seanor HE. Trimeprazine in pediatric practice. Two years clinical experience. N Y State J Med 1961; 61: 1537–8. 75. Sep-Kowalik B. Theralene as an antipsychotic drug in the light of our clinical observations. (Article in Polish). Neurol Neurochir Psychiatr Pol 1966; 16 (10): 1173–7. 76. Shamanina VM, Zavidovskaia GI. Therapeutic evaluation of teralene in the treatment of depressive conditions. (Article in Russian). Zh Nevropatol Psikhiatr Im S.S.Korsakova 1964; 64: 1741–6. 77. Sigwald J, Raymondeaud C. Unpleasant or painful reactions of Parkinson's disease and of the neuroleptic therapy (paresthesia, impatience, cramps, akathisia). Their improvement by alimemazine. (Article in French). Sem Hop 1968; 44 (47): 2897–9. 78. Simard-Savoie S, Tetreault L. Experimental study of the analgesic properties of trimeprazine, haloperidol and trimepramine. (Article in French). Rev Can Biol 1965; 24: 53–62. 79. Simard-Savoie S. Clinical evaluation of the analgesic activity of trimeprazine, codeine and a placebo on postoperative and periodontic pain. 1. Experimental protocol. (Article in French). J Can Dent Assoc (Tor) 1968; 34 (3): 118–22. 80. Slavich A, Tesi L, Bombonato MP. Psychopathologic and therapeutic considerations on the premenstrual syndrome. (Article in Italian). Rass Neuropsichiatr 1964; 18: 37–50. 81. Smith BL, Manford ML. Postoperative vomiting after paediatric adenotonsillectomy. A survey of incidence following differing pre- and postoperative drugs. Br J Anaesth 1974; 46 (5): 373–8. 82. Smith MA, Curwen MP. Controlled trials of two oral antipruritic drugs, trimeprazine and methdilazine. Br J Dermatol 1961; 73: 351–8. 83. Smith PJr, Cazort AG, Jonhston TG et al. Double-blind crossover study of antipruritic effect of chlorcyclizine hydrochloride, trimeprazine, and a placebo. South Med J 1962; 55: 643–5. 84. Sukhovskii AA, Shumskii NG. Teralen treatment of depresive states in old age. (Article in Russian). Zh Nevropatol Psikhiatr Im S.S.Korsakova 1969; 69 (6): 922–5. 85. Tatsumi M, Jansen K, Blakely RD et al. Pharmacological profile of neuroleptics at human monoamine transporters. Eur J Pharmacol 1999; 368 (2–3): 277–83. 86. Thomas DL, Vaughan RS, Vickers MD et al. Comparison of temazepam elixir and trimeprazine syrup as oral premedication in children undergoing tonsillectomy and associated procedures. Br J Anaesth 1987; 59 (4): 424–30. 87. Timofeev NN, Timofeeva AN, Zamakhover ShM. Theralene and its therapeutic effect on the structure of depression. (Article in Russian). Zh Nevropatol Psikhiatr Im S.S.Korsakova 1966; 66 (12): 1855–64. 88. Tindall JP. Relieving localized and generalized pruritus. Geriatrics 1975; 30 (3): 85–8; 91–2. 89. Tran VT, Chang RS, Snyder SH. Histamine H1 receptors identified in mammalian brain membranes with (3H) mepyramine. Proc Natl Acad Sci USA 1978; 75 (12): 6290–4. 90. Varshney R, Kale RK. Effects of calmodulin antagonists on radiation–induced lipid peroxidation in microsomes. Int J Radiat Biol 1990; 58 (5): 733–43. 91. von Maur K. Antihistamine selection in patients with allergic rhinitis. Ann Allergy 1985; 55 (3): 458–62. 92. Wander TJ, Nelson A, Okazaki H et al. Antagonism by neuroleptics of serotonin 5-HT1A and 5-HT2 receptors of normal human brain in vitro. Eur J Pharmacol 1987; 143 (2): 279–82. 93. Werner V, Diehl LW. The state of psychopharmacotherapy in geriatrics 2. (Article in German. Ther Ggw 1980; 119 (12): 1436–47. 94. Wik G. Effects of neuroleptic treatment on cortisol and 3-methoxy-4-hydroxyphenylethyl glycol levels in blood. J Endocrinol 1995; 144 (3): 425–9. 95. Yakhno NN, Parfenov VA, Reyhart DV et al. The multicenter non-interventional, prospective observational program on the study of practical use of teraligen in patients diagnosed with autonomic disorder (START2): a local Russian experience with the use of the Russian version of The Four-Dimensional Symptom Questionnaire (4DSQ). An intermediate analysis. (Article in Russian). Zh Nevrol Psikhiatr Im S.S.Korsakova 2015; 115 (5): 27–33. 96. Younus M, Labellarte MJ. Insomnia in children: when are hypnotics indicated? Paediatr Drugs 2002; 4 (6): 391–403. 97. Zoila AF, Basset J, Lebreton M. Alimemazine tartrate (RP 6549) in psychiatric therapeutics. (Article in French). Presse Med 1959; 67 (23): 935–6.